AFFILIATES:

Brookline Capital Markets

Brookline Capital Markets

Investment Banking for the Healthcare Sector

Brookline at a Glance:

The Brookline Capital Markets Group has extensive experience providing capital markets and advisory services to public and private life sciences, medical technology, and diagnostics companies, Special Purpose Acquisition Companies (“SPACs”), and other emerging growth enterprises.

Brookline is recognized for its differentiated ability to source capital from traditional institutional investors, as well as from its proprietary network of global family offices and high net worth investors. Our greatest source of pride is the success and longevity of our clients as they grow and flourish.

0 +
TRANSACTIONS COMPLETED TO DATE
$ 0
VALUE OF ALL TRANSACTIONS
$ 0 MM
IN PRIVATE CAPITAL MARKETS TRANSACTIONS
0 YEARS
AVERAGE EXPERIENCE ON OUR LEADERSHIP TEAM

The Bookline Brief

Our Monthly Insight into U.S. Healthcare Equity Markets

Undeterred by a host of potential macroeconomic headwinds – ranging from a near-term “tapering” by the Federal Reserve of its ongoing bond-buying programs to the frustrating and increasingly disruptive resilience of the novel SARS nCoV-2 coronavirus in the US and around the globe – US equities nevertheless capped off the finale to Summer 2021 on a high note, with major indices like the Dow, NASDAQ, and Russell 2000 each climbing higher by +1.2%, +4.0%, and +2.1%, respectively, over the past month.
Brookline is hosting the Brookline Capital Markets Biotech Symposium on July 26, 2021 at the Tennis Hall of Fame in Newport, Rhode Island. The theme of the meeting is “Transformative Biotech – Cancer, Rare Diseases and Viruses.”

Brookline Biotech Symposium